Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: J Neural Transm (Vienna). 2021 Dec 29;129(1):95–103. doi: 10.1007/s00702-021-02455-4

Table 1.

Comparison of bipolar disorder cases and control group.

Characteristic BD (n = 15) Control (n = 15) p
Age (years), mean (SD)a 65.8 (13.8) 63.0 (11.6) 0.50
Female, n (%)b 11 (73.3) 11 (73.3) 1.00
BMI (kg/m2), mean (SD)a 24.2 (5.4) 24.1 (5.9) 0.81
Ethnicity, n (%)b
 White/mixed 10 (66.6) 8 (53.3)
 Black 5 (33.3) 7 (46.6) 0.58
Cognitive impairment, n (%)b 2 (13.4) 0 (100.0) 0.48
NPI total score, mean (SD)a 54.8 (33.1) 1.0 (2.4) 0.0001
PMI (hours), mean (SD)a 13.9 (2.52) 15.7 (5.0) 0.20
Current alcohol use, n (%)b 7 (46.6) 6 (40.0) 1.00
Hypertension, n (%)b 8 (53.3) 9 (60.0) 1.00
Diabetes mellitus, n (%)b 6 (40.0) 2 (13.3) 0.21
Coronary artery disease, n (%)b 4 (26.6) 4 (26.6) 1.00
TDP-43 (pg/mL), mean (SD)a 865.7 (177.8) 617.9 (211.9) 0.004

BD bipolar disorder; SD standard deviation; BMI body mass index; NPI neuropsychiatric inventory; PMI postmortem interval; TDP-43 TAR DNA-binding protein 43; N number of cases %: percentage; CDR cognitive dementia rating

a

Mann–Whitney test

b

Fisher exact test